Informe científico de la American Heart Association | 05 JUL 21

Obesidad y enfermedad cardiovascular

El tejido adiposo intravisceral es un claro peligro para la salud
Autor/a: Tiffany M. Powell-Wiley, Paul Poirier, Lora E. Burke, Jean-Pierre Després y otros Circulation. 2021;143:0000.
INDICE:  1. Texto principal | 2. Referencias bibliográficas (1-150) | 3. Referencias bibliográficas (151-312)
Referencias bibliográficas (1-150)

1.    Loos RJ. Genetic determinants of common obesity and their value in pre- diction. Best Pract Res Clin Endocrinol Metab. 2012;26:211–226. doi: 10.1016/j.beem.2011.11.003
2.    Gebreab SZ, Vandeleur CL, Rudaz D, Strippoli MF, Gholam-Rezaee M, Castelao E, Lasserre AM, Glaus J, Pistis G, Kuehner C, et al. Psychoso- cial stress over the lifespan, psychological factors, and cardiometa- bolic risk in the community. Psychosom Med. 2018;80:628–639. doi: 10.1097/PSY.0000000000000621
3.    Sommer I, Griebler U, Mahlknecht P, Thaler K, Bouskill K, Gartlehner G, Mendis S. Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews. BMC Public Health. 2015;15:914. doi: 10.1186/s12889-015-2227-y
4.    Sallis JF, Glanz K. Physical activity and food environments: solutions to the obesity epidemic. Milbank Q. 2009;87:123–154. doi: 10.1111/j.1468- 0009.2009.00550.x
5.    Franks PW, McCarthy MI. Exposing the exposures responsible for type 2 diabetes and obesity. Science. 2016;354:69–73. doi: 10.1126/science. aaf5094
6.    Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a disease: The Obesity Society 2018 position statement. Obesity (Silver Spring). 2019;27:7–9. doi: 10.1002/oby.22378
7.    Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, et al. 2013 AHA/ ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(suppl 2):S102–S138. doi: 10.1161/01. cir.0000437739.71477.ee
8.    Gordon-Larsen P, Heymsfield SB. Obesity as a disease, not a behavior. Circula- tion. 2018;137:1543–1545. doi: 10.1161/CIRCULATIONAHA.118.032780
9.    Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation on Obesity, Geneva, 3–5 June 1997. World Health Organi- zation, Division of Noncommunicable Disease, Programme of Nutrition Family and Reproductive Health; 1998.
10.    Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo- Clavell ML, Korinek J, Allison TG, Batsis JA, Sert-Kuniyoshi FH, Lopez- Jimenez F. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32:959–966. doi: 10.1038/ijo.2008.11
11.    Pack QR, Rodriguez-Escudero JP, Thomas RJ, Squires RW, Johnson L, Somers VK, Lopez-Jimenez F. Diagnostic performance of weight loss to predict body fatness improvement in cardiac rehabilitation patients. J Cardiopulm Rehabil Prev. 2013;33:68–76. doi: 10.1097/HCR.0b013e31827fe7e3
12.    Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond). 2010;34:791–799. doi: 10.1038/ijo.2010.5
13.    Heymsfield SB, Peterson CM, Thomas DM, Heo M, Schuna JM Jr. Why are there race/ethnic differences in adult body mass index-adiposity rela- tionships? A quantitative critical review. Obes Rev. 2016;17:262–275. doi: 10.1111/obr.12358
14.    Rao G, Powell-Wiley TM, Ancheta I, Hairston K, Kirley K, Lear SA, North KE, Palaniappan L, Rosal MC; on behalf of the American Heart Association Obesity Committee of the Council on Lifestyle and Car- diometabolic Health. Identification of obesity and cardiovascular risk in ethnically and racially diverse populations: a scientific statement from the American Heart Association [published correction appears in Circulation. 2015;132:e130]. Circulation. 2015;132:457–472. doi: 10.1161/CIR.0000000000000223
15.    Zhou BF; Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circum- ference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83–96.
16.    Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, Naghavi M, et al; GBD 2015 Obesity Col- laborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.
17.    Maffetone PB, Rivera-Dominguez I, Laursen PB. Overfat and underfat: new terms and definitions long overdue. Front Public Health. 2017;4:e00279. doi: 10.3389/fpubh.2016.00279
18.    Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, de Gonzalez AB, Cairns BJ, Huxley R, Jackson CL, Joshy G, et al; Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: in- dividual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388:776–786.
19.    Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284–2291. doi: 10.1001/jama.2016.6458
20.    Beccia AL, Jesdale WM, Lapane KL. Associations between perceived every- day discrimination, discrimination attributions, and binge eating among Latinas: results from the National Latino and Asian American Study. Ann Epidemiol. 2020;45:32–39. doi: 10.1016/j.annepidem.2020.03.012
21.    Cozier YC, Yu J, Coogan PF, Bethea TN, Rosenberg L, Palmer JR. Racism, segregation, and risk of obesity in the Black Women’s Health Study. Am J Epidemiol. 2014;179:875–883. doi: 10.1093/aje/kwu004
22.    Wu YK, Berry DC, Schwartz TA. Weight stigmatization and binge eating in Asian Americans with overweight and obesity. Int J Env Res Public Health. 2020;17:4319. doi: 10.3390/ijerph17124319
23.    Cuevas AG, Chen R, Slopen N, Thurber KA, Wilson N, Economos C, Williams DR. Assessing the role of health behaviors, socioeconomic status, and cumulative stress for racial/ethnic disparities in obesity. Obesity (Silver Spring). 2020;28:161–170. doi: 10.1002/oby.22648
24.    Bell CN, Kerr J, Young JL. Associations between Obesity, Obesogenic Envi- ronments, and Structural Racism Vary by County-Level Racial Composition. Int J Env Res Public Health. 2019;16:861. doi: 10.3390/ijerph16050861
25.    Chen Y, Freedman ND, Albert PS, Huxley RR, Shiels MS, Withrow DR, Spillane S, Powell-Wiley TM, Berrington de González A. Association of cardiovascular disease with premature mortality in the United States. JAMA Cardiol. 2019;4:1230–1238. doi: 10.1001/jamacardio.2019.3891
26.    Cardel MI, Atkinson MA, Taveras EM, Holm JC, Kelly AS. Obesity treat- ment among adolescents: a review of current evidence and future direc- tions. JAMA Pediatr. 2020;174:609–617. doi: 10.1001/jamapediatrics. 2020.0085
27.    Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obe- sity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898–918. doi: 10.1161/CIRCULATIONAHA.106.171016
28.    Heit JA, Spencer FA, White RH. The epidemiology of venous thrombo- embolism. J Thromb Thrombolysis. 2016;41:3–14. doi: 10.1007/s11239- 015-1311-6
29.    Rahmani J, Roudsari AH, Bawadi H, Thompson J, Fard RK, Clark C, Ryan PM, Ajami M, Sakak FR, Salehisahlabadi A, et al. Relationship between body mass index, risk of venous thromboembolism and pulmonary em- bolism: a systematic review and dose-response meta-analysis of cohort studies among four million participants. Thromb Res. 2020;192:64–72. doi: 10.1016/j.thromres.2020.05.014
30.    Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Millán D, Vila N, Ibañez P, Gil MJ, Valentí V, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adi- posity. Int J Obes (Lond). 2012;36:286–294. doi: 10.1038/ijo.2011.100
31.    Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J, Jensen MD, Parati G, Lopez-Jimenez F. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortal- ity. Eur Heart J. 2010;31:737–746. doi: 10.1093/eurheartj/ehp487
32.    Batsis JA, Sahakyan KR, Rodriguez-Escudero JP, Bartels SJ, Somers VK, Lopez-Jimenez F. Normal weight obesity and mortality in United States subjects ≥60 years of age (from the Third National Health and Nutri- tion Examination Survey). Am J Cardiol. 2013;112:1592–1598. doi: 10.1016/j.amjcard.2013.07.014
33.    Piché ME, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascu- lar disease: an update. Prog Cardiovasc Dis. 2018;61:103–113. doi: 10.1016/j.pcad.2018.06.004
34.    Sahakyan KR, Somers VK, Rodriguez-Escudero JP, Hodge DO, Carter RE, Sochor O, Coutinho T, Jensen MD, Roger VL, Singh P, et al. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med. 2015;163:827–835. doi: 10.7326/M14-2525
35.    Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, Kushner RF, Daniels SR, Wadden TA, Tsai AG, et al. The science of obesity manage- ment: an Endocrine Society scientific statement. Endocr Rev. 2018;39:79– 132. doi: 10.1210/er.2017-00253
36.    Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical En- docrinologists and American College of Endocrinology Comprehensive clinical practice guidelines For medical care of patients with obesity. En- docr Pract. 2016;22(suppl 3):1–203. doi: 10.4158/EP161365.GL
37.    Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, Jerosch-Herold M, Lima JAC, Ding JZ, Allison MA, et al. Visceral adi- posity and the risk of metabolic syndrome across body mass index: the MESA study. J Am Coll Cardiol Cardiovasc Imag. 2014;7:1222–1235. doi: 10.1016/j.jcmg.2014.07.017
38.    Abraham TM, Pedley A, Massaro JM, Hoffmann U, Fox CS. Associa- tion between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015;132:1639–1647. doi: 10.1161/CIRCULATIONAHA.114.015000
39.    Tatsumi Y, Nakao YM, Masuda I, Higashiyama A, Takegami M, Nishimura K, Watanabe M, Ohkubo T, Okamura T, Miyamoto Y. Risk for meta- bolic diseases in normal weight individuals with visceral fat accumula- tion: a cross-sectional study in Japan. BMJ Open. 2017;7:e013831. doi: 10.1136/bmjopen-2016-013831
40.    Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39–48. doi: 10.1161/CIRCULATIONAHA.106.675355
41.    Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, Vega GL, Khera A, McGuire DK, Grundy SM, et al. Associations of visceral and ab- dominal subcutaneous adipose tissue with markers of cardiac and meta- bolic risk in obese adults. Obesity (Silver Spring). 2013;21:E439–E447. doi: 10.1002/oby.20135
42.    Neeland IJ, Poirier P, Després JP. Cardiovascular and metabolic het- erogeneity of obesity: clinical challenges and implications for management. Circulation. 2018;137:1391–1406. doi: 10.1161/ CIRCULATIONAHA.117.029617
43.    Nazare JA, Smith J, Borel AL, Aschner P, Barter P, Van Gaal L, Tan CE, Wittchen HU, Matsuzawa Y, Kadowaki T, et al. Usefulness of mea- suring both body mass index and waist circumference for the estima- tion of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA Study). Am J Cardiol. 2015;115:307–315. doi: 10.1016/j.amjcard.2014.10.039
44.    Lee JJ, Pedley A, Hoffmann U, Massaro JM, Levy D, Long MT. Visceral and intrahepatic fat are associated with cardiometabolic risk factors above other ectopic fat depots: the Framingham Heart Study. Am J Med. 2018;131:684–692.e12. doi: 10.1016/j.amjmed.2018.02.002
45.    Ross R, Bradshaw AJ. The future of obesity reduction: beyond weight loss.
Nat Rev Endocrinol. 2009;5:319–325. doi: 10.1038/nrendo.2009.78
46.    Després JP. Body fat distribution and risk of cardiovascular dis- ease: an update. Circulation. 2012;126:1301–1313. doi: 10.1161/ CIRCULATIONAHA.111.067264
47.    Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, Suzuki S, Takaya N, Nakagawa T, Fukui T, et al. Absolute value of vis- ceral fat area measured on computed tomography scans and obesi- ty-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med. 2012;44:82–92. doi: 10.3109/07853890.2010.526138
48.    Després JP. What is “metabolically healthy obesity”? From epidemiology to pathophysiological insights. J Clin Endocrinol Metab. 2012;97:2283– 2285. doi: 10.1210/jc.2012-2081
49.    Camhi SM, Must A, Gona PN, Hankinson A, Odegaard A, Reis J, Gunderson EP, Jacobs DR, Carnethon MR. Duration and stability of meta- bolically healthy obesity over 30 years. Int J Obes (Lond). 2019;43:1803– 1810. doi: 10.1038/s41366-018-0197-8
50.    Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Na- ture. 2006;444:881–887. doi: 10.1038/nature05488
51.    Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all- cause mortality. J Am Coll Cardiol. 2013;62:921–925. doi: 10.1016/j. jacc.2013.06.027
52.    Mongraw-Chaffin M, Allison MA, Burke GL, Criqui MH, Matsushita K, Ouyang P, Shah RV, Shay CM, Anderson CAM. CT-derived body fat dis- tribution and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. J Clin Endocrinol Metab. 2017;102:4173–4183. doi: 10.1210/jc.2017-01113
53.    Neeland IJ, Turer AT, Ayers CR, Berry JD, Rohatgi A, Das SR, Khera A, Vega GL, McGuire DK, Grundy SM, de Lemos JA. Body fat distribution and incident cardiovascular disease in obese adults. J Am Coll Cardiol. 2015;65:2150–2151. doi: 10.1016/j.jacc.2015.01.061
54.    Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in he- patic steatosis: an insulin resistance paradox? Hepatology. 2009;49:791– 801. doi: 10.1002/hep.22726
55.    Nazare JA, Smith JD, Borel AL, Haffner SM, Balkau B, Ross R, Massien C, Alméras N, Després JP. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardio- metabolic risk profile: the International Study of Prediction of Intra- Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/ Intra-Abdominal Adiposity. Am J Clin Nutr. 2012;96:714–726. doi: 10.3945/ajcn.112.035758
56.    Lim S, Taskinen MR, Borén J. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obes Rev. 2019;20:599–611. doi: 10.1111/obr.12820
57.    omentectomy. Diabetes Care. 2010;33:1693–1694. doi: 10.2337/dc10-0744
58.    Lauridsen BK, Stender S, Kristensen TS, Kofoed KF, Køber L, Nordestgaard BG, Tybjærg-Hansen A. Liver fat content, non-alcoholic fatty liver dis- ease, and ischaemic heart disease: Mendelian randomization and me- ta-analysis of 279 013 individuals. Eur Heart J. 2018;39:385–393. doi: 10.1093/eurheartj/ehx662
59.    Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the meta- bolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225–1236. doi: 10.1161/ATVBAHA.107.160192
60.    Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14:32–42. doi: 10.1038/nrgastro.2016.147
61.    Ndumele CE, Nasir K, Conceiçao RD, Carvalho JA, Blumenthal RS, Santos RD. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic in- flammation. Arterioscler Thromb Vasc Biol. 2011;31:1927–1932. doi: 10.1161/ATVBAHA.111.228262
62.    Iacobellis G. Epicardial and pericardial fat: close, but very different. Obe- sity (Silver Spring). 2009;17:625; author reply 626; author reply 627. doi: 10.1038/oby.2008.575
63.    Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, O’Donnell CJ, Fox CS, Hoffmann U. Association of pericardial fat, intra- thoracic fat, and visceral abdominal fat with cardiovascular disease bur- den: the Framingham Heart Study. Eur Heart J. 2009;30:850–856. doi: 10.1093/eurheartj/ehn573
64.    Ong KL, Ding J, McClelland RL, Cheung BM, Criqui MH, Barter PJ, Rye KA, Allison MA. Relationship of pericardial fat with lipoprotein distribution: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2015;241:664– 670. doi: 10.1016/j.atherosclerosis.2015.06.027
65.    Shah RV, Anderson A, Ding JZ, Budoff M, Rider O, Petersen SE, Jensen MK, Koch M, Allison M, Kawel-Boehm N, et al. Pericardial, but not hepat- ic, fat by CT Is Associated With cv outcomes and structure: the Multi-Eth- nic Study of Atherosclerosis. JACC Cardiovasc Imag. 2017;10:1016–1027. doi: 10.1016/j.jcmg.2016.10.024
66.    Larsen BA, Laughlin GA, Saad SD, Barrett-Connor E, Allison MA, Wassel CL. Pericardial fat is associated with all-cause mortality but not incident CVD: the Rancho Bernardo Study. Atherosclerosis. 2015;239:470–475. doi: 10.1016/j.atherosclerosis.2015.02.022
67.    Iacobellis G. Local and systemic effects of the multifaceted epicar- dial adipose tissue depot. Nat Rev Endocrinol. 2015;11:363–371. doi: 10.1038/nrendo.2015.58
68.    Hruskova J, Maugeri A, Podrouzkova H, Stipalova T, Jakubik J, Barchitta M, Medina-Inojosa JR, Homolka M, Agodi A, Kunzova S, et al. Associa- tion of cardiovascular health with epicardial adipose tissue and intima media thickness: the Kardiovize study. J Clin Med. 2018;7:113. doi: 10.3390/jcm7050113
69.    Al-Talabany S, Mordi I, Graeme Houston J, Colhoun HM, Weir-McCall JR, Matthew SZ, Looker HC, Levin D, Belch JJF, Dove F, et al. Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes. BMC Cardiovasc Disord. 2018;18:31. doi: 10.1186/s12872-018-0770-z
70.    Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syn- drome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88:5163–5168. doi: 10.1210/jc.2003-030698
71.    Akilli H, Kayrak M, Bekci TT, Erdogan HI, Aribas A, Yildirim O, Taner A, Erer M, Unlu A. Gender-related changes of the epicardial fat thickness and leptin in obstructive sleep apnea. Echocardiography. 2014;31:411–419. doi: 10.1111/echo.12392
72.    St-Onge MP, Grandner MA, Brown D, Conroy MB, Jean-Louis G, Coons M, Bhatt DL; on behalf of the American Heart Association Obesity, Behavior Change, Diabetes, and Nutrition Committees of the Council on Lifestyle and Cardiometabolic Health; Council on Cardio- vascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Sleep duration and quality: impact on lifestyle be- haviors and cardiometabolic health: a scientific statement from the American Heart Association. Circulation. 2016;134:e367–e386. doi: 10.1161/CIR.0000000000000444 Ng SS, Liu EK, Ma RC, Chan TO, To KW, Chan KK, Ngai J, Yip WH, Ko FW, Wong CK, et al. Effects of CPAP therapy on visceral fat thick- ness, carotid intima-media thickness and adipokines in patients with obstructive sleep apnoea. Respirology. 2017;22:786–792. doi: 10.1111/resp.12963
73.    Sivam S, Phillips CL, Trenell MI, Yee BJ, Liu PY, Wong KK, Grunstein RR. Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur Respir J. 2012;40:913–918. doi: 10.1183/09031936.00177011
74.    Fujimoto WY, Jablonski KA, Bray GA, Kriska A, Barrett-Connor E, Haffner S, Hanson R, Hill JO, Hubbard V, Stamm E, et al; Diabetes Prevention Pro- gram Research Group. Body size and shape changes and the risk of dia- betes in the Diabetes Prevention Program. Diabetes. 2007;56:1680–1685. doi: 10.2337/db07-0009
75.    Rao S, Pandey A, Garg S, Park B, Mayo H, Després JP, Kumbhani D, de Lemos JA, Neeland IJ. Effect of exercise and pharmacological interven- tions on visceral adiposity: a systematic review and meta-analysis of long- term randomized controlled trials. Mayo Clin Proc. 2019;94:211–224. doi: 10.1016/j.mayocp.2018.09.019
76.    Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men: a randomized, con- trolled trial. Ann Intern Med. 2000;133:92–103. doi: 10.7326/0003- 4819-133-2-200007180-00008
77.    Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, Wong SL, Nguyen-Duy TB, Lee S, Kilpatrick K, Hudson R. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res. 2004;12:789–798. doi: 10.1038/oby.2004.95
78.    Boudou P, de Kerviler E, Erlich D, Vexiau P, Gautier JF. Exercise training-in- duced triglyceride lowering negatively correlates with DHEA levels in men with type 2 diabetes. Int J Obes Relat Metab Disord. 2001;25:1108–1112. doi: 10.1038/sj.ijo.0801637
79.    Verheggen RJ, Maessen MF, Green DJ, Hermus AR, Hopman MT, Thijssen DH. A systematic review and meta-analysis on the effects of exercise train- ing versus hypocaloric diet: distinct effects on body weight and visceral adipose tissue. Obes Rev. 2016;17:664–690. doi: 10.1111/obr.12406
80.    Cruz P, Johnson BD, Karpinski SC, Limoges KA, Warren BA, Olsen KD, Somers VK, Jensen MD, Clark MM, Lopez-Jimenez F. Validity of weight loss to estimate improvement in body composition in individuals attend- ing a wellness center. Obesity (Silver Spring). 2011;19:2274–2279. doi: 10.1038/oby.2011.102
81.    Lesser IA, Singer J, Hoogbruin A, Mackey DC, Katzmarzyk PT, Sohal P, Leipsic J, Lear SA. Effectiveness of exercise on visceral adipose tissue in older South Asian women. Med Sci Sports Exerc. 2016;48:1371–1378. doi: 10.1249/MSS.0000000000000906
82.    Cooper JH, Collins BE, Adams DR, Robergs RA, Donges CE. Limited effects of endurance or interval training on visceral adipose tissue and systemic in- flammation in sedentary middle-aged men. J Obes. 2016;2016:2479597. doi: 10.1155/2016/2479597
83.    Hintze LJ, Messier V, Lavoie MÈ, Brochu M, Lavoie JM, Prud’homme D, Rabasa-Lhoret R, Doucet É. A one-year resistance training pro- gram following weight loss has no significant impact on body com- position and energy expenditure in postmenopausal women living with overweight and obesity. Physiol Behav. 2018;189:99–106. doi: 10.1016/j.physbeh.2018.03.014
84.    Slentz CA, Bateman LA, Willis LH, Shields AT, Tanner CJ, Piner LW, Hawk VH, Muehlbauer MJ, Samsa GP, Nelson RC, et al. Effects of aero- bic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. Am J Physiol Endocrinol Metab. 2011;301:E1033–E1039. doi: 10.1152/ajpendo.00291.2011
85.    Maillard F, Rousset S, Pereira B, Traore A, de Pradel Del Amaze P, Boirie Y, Duclos M, Boisseau N. High-intensity interval training reduces abdomi- nal fat mass in postmenopausal women with type 2 diabetes. Diabetes Metab. 2016;42:433–441. doi: 10.1016/j.diabet.2016.07.031
86.    Zhang H, Tong TK, Qiu W, Zhang X, Zhou S, Liu Y, He Y. Comparable ef- fects of high-intensity interval training and prolonged continuous exercise training on abdominal visceral fat reduction in obese young women. J Diabetes Res. 2017;2017:5071740. doi: 10.1155/2017/5071740
87.    Herzig KH, Ahola R, Leppäluoto J, Jokelainen J, Jämsä T, Keinänen- Kiukaanniemi S. Light physical activity determined by a motion sensor decreases insulin resistance, improves lipid homeostasis and reduces visceral fat in high-risk subjects: PreDiabEx study RCT. Int J Obes (Lond). 2014;38:1089–1096. doi: 10.1038/ijo.2013.224                                                                                                        
88.    Friedenreich CM, Neilson HK, O’Reilly R, Duha A, Yasui Y, Morielli AR, Adams SC, Courneya KS. Effects of a high vs moderate volume of aerobic exercise on adiposity outcomes in postmenopausal women: a randomized clinical trial. JAMA Oncol. 2015;1:766–776. doi: 10.1001/ jamaoncol.2015.2239
89.    van Gemert WA, Peeters PH, May AM, Doornbos AJH, Elias SG, van der Palen J, Veldhuis W, Stapper M, Schuit JA, Monninkhof EM. Effect of diet with or without exercise on abdominal fat in postmeno- pausal women: a randomised trial. BMC Public Health. 2019;19:174. doi: 10.1186/s12889-019-6510-1
90.    Trussardi Fayh AP, Lopes AL, Fernandes PR, Reischak-Oliveira A, Friedman
R. Impact of weight loss with or without exercise on abdominal fat and insulin resistance in obese individuals: a randomised clinical trial. Br J Nutr. 2013;110:486–492. doi: 10.1017/S0007114512005442
91.    Murphy JC, McDaniel JL, Mora K, Villareal DT, Fontana L, Weiss EP. Preferential reductions in intermuscular and visceral adipose tissue with exercise-induced weight loss compared with calorie restriction. J Appl Physiol (1985). 2012;112:79–85. doi: 10.1152/japplphysiol.00355.2011
92.    Giannopoulou I, Ploutz-Snyder LL, Carhart R, Weinstock RS, Fernhall B, Goulopoulou S, Kanaley JA. Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2005;90:1511–1518. doi: 10.1210/jc.2004-1782
93.    Pedersen LR, Olsen RH, Jürs A, Astrup A, Chabanova E, Simonsen L, Wisløff U, Haugaard SB, Prescott E. A randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: the CUT-IT trial. Eur J Prev Cardiol. 2015;22:1009–1017. doi: 10.1177/2047487314545280
94.    Gallagher D, Heshka S, Kelley DE, Thornton J, Boxt L, Pi-Sunyer FX, Patricio J, Mancino J, Clark JM; MRI Ancillary Study Group of Look AHEAD Research Group. Changes in adipose tissue depots and metabol- ic markers following a 1-year diet and exercise intervention in overweight and obese patients with type 2 diabetes. Diabetes Care. 2014;37:3325– 3332. doi: 10.2337/dc14-1585
95.    Keating SE, Hackett DA, Parker HM, O’Connor HT, Gerofi JA, Sainsbury A, Baker MK, Chuter VH, Caterson ID, George J, et al. Effect of aero- bic exercise training dose on liver fat and visceral adiposity. J Hepatol. 2015;63:174–182. doi: 10.1016/j.jhep.2015.02.022
96.    Zhang HJ, Pan LL, Ma ZM, Chen Z, Huang ZF, Sun Q, Lu Y, Han CK, Lin MZ, Li XJ, et al. Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: a 1-year follow-up study. Diabetes Obes Metab. 2017;19:284–289. doi: 10.1111/dom.12809
97.    Fernandez-del-Valle M, Gonzales JU, Kloiber S, Mitra S, Klingensmith J, Larumbe-Zabala E. Effects of resistance training on MRI-derived epi- cardial fat volume and arterial stiffness in women with obesity: a ran- domized pilot study. Eur J Appl Physiol. 2018;118:1231–1240. doi: 10.1007/s00421-018-3852-9
98.    Honkala SM, Motiani KK, Eskelinen JJ, Savolainen A, Saunavaara V, Virtanen KA, Löyttyniemi E, Kapanen J, Knuuti J, Kalliokoski KK, et al. Exercise training reduces intrathoracic fat regardless of defective glucose tolerance. Med Sci Sports Exerc. 2017;49:1313–1322. doi: 10.1249/MSS.0000000000001232
99.    Rabkin SW, Campbell H. Comparison of reducing epicardial fat by exer- cise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis. Obes Rev. 2015;16:406–415. doi: 10.1111/obr.12270
100.    Yoshimura E, Kumahara H, Tobina T, Matsuda T, Ayabe M, Kiyonaga A, Anzai K, Higaki Y, Tanaka H. Lifestyle intervention involving calo- rie restriction with or without aerobic exercise training improves liver fat in adults with visceral adiposity. J Obes. 2014;2014:197216. doi: 10.1155/2014/197216
101.    Brinkley TE, Ding J, Carr JJ, Nicklas BJ. Pericardial fat loss in postmeno- pausal women under conditions of equal energy deficit. Med Sci Sports Exerc. 2011;43:808–814. doi: 10.1249/MSS.0b013e3181fb512d
102.    Hsieh SD, Yoshinaga H. Abdominal fat distribution and coronary heart disease risk factors in men: waist/height ratio as a simple and useful pre- dictor. Int J Obesity. 1995;19:585–589.
103.    Ashwell M, Gibson S. Waist-to-height ratio as an indicator of “early health risk”: simpler and more predictive than using a “matrix” based on BMI and waist circumference. BMJ Open. 2016;6:e010159. doi: 10.1136/bmjopen-2015-010159
104.    Coutinho T, Goel K, de Sa DC, Carter RE, Hodge DO, Kragelund C, Kanaya AM, Zeller M, Park JS, Kober L, et al. Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of “normal weight central obesity.” J Am Coll Cardiol. 2013;61:553–560. doi: 10.1016/j.jacc.2012.10.035 McGill HC Jr. Fatty streaks in the coronary arteries and aorta. Lab Invest. 1968;18:560–564.
105.    Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP 3rd, Herderick EE, Cornhill JF. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999;281:727–735. doi: 10.1001/jama.281.8.727
106.    McGill HC Jr, McMahan CA, Herderick EE, Zieske AW, Malcom GT, Tracy RE, Strong JP; for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation. 2002;105:2712– 2718. doi: 10.1161/01.cir.0000018121.67607.ce
107.    Berenson GS, Srinivasan SR, Bao WH, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk fac- tors and atherosclerosis in children and young adults. N Engl J Med. 1998;338:1650–1656. doi: 10.1056/NEJM199806043382302
108.    McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP, Wissler RW, Robertson AL, Cornhill JF, Gay S, Gay RE, et al. Relation of glycohe- moglobin and adiposity to atherosclerosis in youth. Arterioscler Throm Vasc Biol. 1995;15:431–440. doi: 10.1161/01.atv.15.4.431
109.    Zieske AW, Malcom GT, Strong JP. Natural history and risk factors of ath- erosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med. 2002;21:213–237. doi: 10.1080/15227950252852104
110.    Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 2009;6:399–409. doi: 10.1038/nrcardio.2009.55
111.    Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138(pt 2):S419–S420. doi: 10.1016/s0002-8703(99)70266-8
112.    Couillard C, Ruel G, Archer WR, Pomerleau S, Bergeron J, Couture P, Lamarche B, Bergeron N. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab. 2005;90:6454–6459. doi: 10.1210/jc.2004-2438
113.    Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26:364–373. doi: 10.1016/j.tcm.2015.10.004
114.    Engin A. Endothelial dysfunction in obesity. Adv Exp Med Biol. 2017;960:345–379. doi: 10.1007/978-3-319-48382-5_15
115.    De Michele M, Panico S, Iannuzzi A, Celentano E, Ciardullo AV, Galasso R, Sacchetti L, Zarrilli F, Bond MG, Rubba P. Association of obesity and central fat distribution with carotid artery wall thickening in middle- aged women. Stroke. 2002;33:2923–2928. doi: 10.1161/01.str. 0000038989.90931.be
116.    Freedman DS, Dietz WH, Tang R, Mensah GA, Bond MG, Urbina EM, Srinivasan S, Berenson GS. The relation of obesity throughout life to ca- rotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord. 2004;28:159–166. doi: 10.1038/sj.ijo.0802515
117.    Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–1105. doi: 10.1056/NEJM199910073411501
118.    Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an inde- pendent risk factor for cardiovascular disease: a 26-year follow-up of par- ticipants in the Framingham Heart Study. Circulation. 1983;67:968–977. doi: 10.1161/01.cir.67.5.968
119.    Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE. Body weight and mortality among women. N Engl J Med. 1995;333:677–685. doi: 10.1056/NEJM199509143331101
120.    Folsom AR, Stevens J, Schreiner PJ, McGovern PG. Body mass in- dex, waist/hip ratio, and coronary heart disease incidence in African Americans and Whites: Atherosclerosis Risk in Communities Study Investigators. Am J Epidemiol. 1998;148:1187–1194. doi: 10.1093/ oxfordjournals.aje.a009608
121.    Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, van Dam RM, Hu FB, Visscher TL, Menotti A, et al; BMI-CHD Collaboration Investigators. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167:1720–1728. doi: 10.1001/archinte.167.16.1720
122.    Canoy D, Cairns BJ, Balkwill A, Wright FL, Green J, Reeves G, Beral V; Million Women Study Collaborators. Coronary heart disease incidence in women by waist circumference within categories of body mass index. Eur J Prev Cardiol. 2013;20:759–762. doi: 10.1177/2047487313492631
123.    Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117:1658–1667. doi:10.1161/CIRCULATIONAHA.107.739714
124.    Reis JP, Allen N, Gunderson EP, Lee JM, Lewis CE, Loria CM, Powell-Wiley TM, Rana JS, Sidney S, Wei G, et al. Excess body mass index- and waist circumference-years and incident cardiovascular disease: the CARDIA study. Obesity (Silver Spring). 2015;23:879–885. doi: 10.1002/oby.21023
125.    Ndumele CE, Matsushita K, Lazo M, Bello N, Blumenthal RS, Gerstenblith G, Nambi V, Ballantyne CM, Solomon SD, Selvin E, et al. Obesity and subtypes of incident cardiovascular disease. J Am Heart Assoc. 2016;5:e003921. doi: 10.1161/JAHA.116.003921
126.    Wilson PW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation. 2008;118:124–130. doi: 10.1161/CIRCULATIONAHA.108.772962
127.    Mørkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trøndelag Health Study), Norway. J Am Coll Cardiol. 2014;63:1071–1078. doi: 10.1016/j.jacc.2013.11.035
128.    Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without meta- bolic syndrome. JAMA Intern Med. 2014;174:15–22. doi: 10.1001/ jamainternmed.2013.10522
129.    Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L, Huerta JM, Agnoli C, Freisling H, Weiderpass E, et al. Separate and combined as- sociations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J. 2018;39:397–406. doi: 10.1093/eurheartj/ehx448
130.    Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G; Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass in- dex, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383:970–983. doi: 10.1016/S0140-6736(13)61836-X
131.    Shimabukuro M, Hirata Y, Tabata M, Dagvasumberel M, Sato H, Kurobe H, Fukuda D, Soeki T, Kitagawa T, Takanashi S, et al. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33:1077– 1084. doi: 10.1161/ATVBAHA.112.300829
132.    Ishii T, Asuwa N, Masuda S, Ishikawa Y. The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J Pathol. 1998;185:4–9. doi: 10.1002/(SICI)1096-9896(199805)185:1<4::AID-PATH50>3.0.CO;2-3
133.    Ishikawa Y, Ishii T, Asuwa N, Masuda S. Absence of atherosclerosis evolution in the coronary arterial segment covered by myocardial tis- sue in cholesterol-fed rabbits. Virchows Arch. 1997;430:163–171. doi: 10.1007/BF01008038
134.    Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imag- ing for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging. 2010;3:623–640. doi: 10.1016/j.jcmg.2010.04.007
135.    Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72:2625–2641. doi: 10.1016/j.jacc.2018.09.042
136.    Lee BK, Lim HS, Fearon WF, Yong AS, Yamada R, Tanaka S, Lee DP, Yeung AC, Tremmel JA. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015;131:1054–1060. doi: 10.1161/CIRCULATIONAHA.114.012636
137.    Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, Dorbala S, Blankstein R, Di Carli MF. Global coronary flow re- serve is associated with adverse cardiovascular events indepen- dently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131:19–27. doi: 10.1161/ CIRCULATIONAHA.114.011939
138.    Schindler TH, Cardenas J, Prior JO, Facta AD, Kreissl MC, Zhang XL, Sayre J, Dahlbom M, Licinio J, Schelbert HR. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol. 2006;47:1188–1195. doi: 10.1016/j.jacc.2005.10.062
139.    Bajaj NS, Osborne MT, Gupta A, Tavakkoli A, Bravo PE, Vita T, Bibbo CF, Hainer J, Dorbala S, Blankstein R, et al. Coronary microvascular dys- function and cardiovascular risk in obese patients. J Am Coll Cardiol. 2018;72:707–717. doi: 10.1016/j.jacc.2018.05.049
140.    Quercioli A, Montecucco F, Pataky Z, Thomas A, Ambrosio G, Staub C, Di Marzo V, Ratib O, Mach F, Golay A, et al. Improvement in coronary circu- latory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocyto- kines. Eur Heart J. 2013;34:2063–2073. doi: 10.1093/eurheartj/eht085 Nomura A, Zareba W, Moss AJ. Obesity does not influence electrocar- diographic parameters in coronary patients. Am J Cardiol. 2000;85:106– 108, A9. doi: 10.1016/s0002-9149(99)00617-7
141.    Adachi H, Hashimoto R, Tsuruta M, Jacobs DR Jr, Crow RS, Imaizumi T. Hyperinsulinemia and the development of ST-T electrocardiographic ab- normalities: an 11-year follow-up study. Diabetes Care. 1997;20:1688– 1692. doi: 10.2337/diacare.20.11.1688
142.    Karason K, Lindroos AK, Stenlöf K, Sjöström L. Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study. Arch Intern Med. 2000;160:1797–1802. doi: 10.1001/archinte.160.12.1797
143.    Gondoni LA, Titon AM, Nibbio F, Augello G, Caetani G, Liuzzi A. Heart rate behavior during an exercise stress test in obese patients. Nutr Metab Cardiovasc Dis. 2009;19:170–176. doi: 10.1016/j.numecd.2008.07.001
144.    Lear SA, Brozic A, Myers JN, Ignaszewski A. Exercise stress testing: an overview of current guidelines. Sports Med. 1999;27:285–312. doi: 10.2165/00007256-199927050-00002
145.    Chrysohoou C, Skoumas J, Georgiopoulos G, Liontou C, Vogiatzi G, Tsioufis K, Lerakis S, Soulis D, Pitsavos C, Tousoulis D. Exercise capac- ity and haemodynamic response among 12,327 individuals with cardio- metabolic risk factors undergoing treadmill exercise. Eur J Prev Cardiol. 2017;24:1627–1636. doi: 10.1177/2047487317726069
146.    Bires AM, Lawson D, Wasser TE, Raber-Baer D. Comparison of Bruce treadmill exercise test protocols: is ramped Bruce equal or superior to standard Bruce in producing clinically valid studies for patients presenting for evaluation of cardiac ischemia or arrhythmia with body mass index equal to or greater than 30? J Nucl Med Technol. 2013;41:274–278. doi: 10.2967/jnmt.113.124727
147.    Korbee RS, Boiten HJ, Ottenhof M, Valkema R, van Domburg RT, Schinkel AF. What is the value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging for the assessment of very long-term outcome in obese patients? J Nucl Cardiol. 2013;20:227–233. doi: 10.1007/s12350-012-9657-z
148.    Chow BJ, Dorbala S, Di Carli MF, Merhige ME, Williams BA, Veledar E, Min JK, Pencina MJ, Yam Y, Chen L, et al. Prognostic value of PET myo- cardial perfusion imaging in obese patients. JACC Cardiovasc Imaging. 2014;7:278–287. doi: 10.1016/j.jcmg.2013.12.008
149.    Supariwala A, Makani H, Kahan J, Pierce M, Bajwa F, Dukkipati SS, Teixeira J, Chaudhry FA. Feasibility and prognostic value of stress echo- cardiography in obese, morbidly obese, and super obese patients re- ferred for bariatric surgery. Echocardiography. 2014;31:879–885. doi: 10.1111/echo.12481
150.    Argulian E, Halpern DG, Agarwal V, Agarwal SK, Chaudhry FA. Predictors of ischemia in patients referred for evaluation of exertional dyspnea: a stress echocardiography study. J Am Soc Echocardiogr. 2013;26:72–76. doi: 10.1016/j.echo.2012.09.012

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2023